Literature DB >> 23716043

Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients.

Yasuhiro Kawai1, Naoyuki Miyashita, Mika Kubo, Hiroto Akaike, Atsushi Kato, Yoko Nishizawa, Aki Saito, Eisuke Kondo, Hideto Teranishi, Tokio Wakabayashi, Satoko Ogita, Takaaki Tanaka, Kozo Kawasaki, Takashi Nakano, Kihei Terada, Kazunobu Ouchi.   

Abstract

We conducted nationwide surveillance to investigate regional differences in macrolide-resistant (MR) Mycoplasma pneumoniae strains in Japan. The prevalence of MR M. pneumoniae in pediatric patients gradually increased between 2008 and 2012. Although regional differences were observed, high levels of MR genes were detected in all seven surveillance areas throughout Japan and ranged in prevalence from 50% to 93%. These regional differences were closely related to the previous administration of macrolides.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23716043      PMCID： PMC3719750          DOI： 10.1128/AAC.00663-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

1.  Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro.

Authors:  N Okazaki; M Narita; S Yamada; K Izumikawa; M Umetsu; T Kenri; Y Sasaki; Y Arakawa; T Sasaki
Journal:  Microbiol Immunol       Date:  2001       Impact factor: 1.955

2.  Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.

Authors:  Miyuki Morozumi; Satoshi Iwata; Keiko Hasegawa; Naoko Chiba; Reiko Takayanagi; Keita Matsubara; Eiichi Nakayama; Keisuke Sunakawa; Kimiko Ubukata
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

3.  Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.

Authors:  Yang Liu; Xinyu Ye; Hong Zhang; Xiaogang Xu; Wanhua Li; Demei Zhu; Minggui Wang
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

4.  Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults.

Authors:  Hiroshi Tanaka; Mitsuo Narita; Shin Teramoto; Toyohiro Saikai; Kensuke Oashi; Tomofumi Igarashi; Shosaku Abe
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

5.  Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon.

Authors:  M Narita; H Tanaka; S Abe; S Yamada; M Kubota; T Togashi
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

6.  Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.

Authors:  Mayumi Matsuoka; Mitsuo Narita; Norio Okazaki; Hitomi Ohya; Tsutomu Yamazaki; Kazunobu Ouchi; Isao Suzuki; Tomoaki Andoh; Tsuyoshi Kenri; Yuko Sasaki; Atsuko Horino; Miharu Shintani; Yoshichika Arakawa; Tsuguo Sasaki
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

Review 7.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas.

Authors:  Ken B Waites; Donna M Crabb; Xue Bing; Lynn B Duffy
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

9.  Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.

Authors:  T S Lucier; K Heitzman; S K Liu; P C Hu
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

10.  Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.

Authors:  Naoyuki Miyashita; Yasuhiro Kawai; Hiroto Akaike; Kazunobu Ouchi; Toshikiyo Hayashi; Takeyuki Kurihara; Niro Okimoto
Journal:  BMC Infect Dis       Date:  2012-05-31       Impact factor: 3.090
View more
  35 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  In vitro antibacterial activity of α-methoxyimino acylide derivatives against macrolide-resistant pathogens and mutation analysis in 23S rRNA.

Authors:  Hiroyuki Sugiyama; Ippei Yoshida; Mayumi Ueki; Katsuhiko Tanabe; Akira Manaka; Keiichi Hiramatsu
Journal:  J Antibiot (Tokyo)       Date:  2017-01-11       Impact factor: 2.649

Review 3.  Delivering macrolide antibiotics to heal a broken heart - And other inflammatory conditions.

Authors:  Vincent J Venditto; David J Feola
Journal:  Adv Drug Deliv Rev       Date:  2022-03-30       Impact factor: 17.873

Review 4.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

5.  Predicting Mycoplasma pneumoniae and Chlamydophila pneumoniae in community-acquired pneumonia (CAP) pneumonia: epidemiological study of respiratory tract infection using multiplex PCR assays.

Authors:  Naoto Ishimaru; Satoshi Suzuki; Toshio Shimokawa; Yusaku Akashi; Yuto Takeuchi; Atsuo Ueda; Saori Kinami; Hisashi Ohnishi; Hiromichi Suzuki; Yasuharu Tokuda; Tetsuhiro Maeno
Journal:  Intern Emerg Med       Date:  2021-05-13       Impact factor: 3.397

6.  Increased Macrolide Resistance Rate of M3562 Mycoplasma pneumoniae Correlated With Macrolide Usage and Genotype Shifting.

Authors:  Yacui Wang; Baoping Xu; Xirong Wu; Qingqin Yin; Yi Wang; Jieqiong Li; Weiwei Jiao; Shuting Quan; Lin Sun; Yonghong Wang; Adong Shen
Journal:  Front Cell Infect Microbiol       Date:  2021-05-12       Impact factor: 5.293

7.  A multisite SNP genotyping and macrolide susceptibility gene method for Mycoplasma pneumoniae based on MALDI-TOF MS.

Authors:  Fei Zhao; Jianzhong Zhang; Xuemei Wang; Liyong Liu; Jie Gong; Zhixiang Zhai; Lihua He; Fanliang Meng; Di Xiao
Journal:  iScience       Date:  2021-04-16

8.  Macrolide-Resistant Mycoplasma pneumoniae, United States.

Authors:  Xiaotian Zheng; Stella Lee; Rangaraj Selvarangan; Xuan Qin; Yi-Wei Tang; Jeffrey Stiles; Tao Hong; Kathleen Todd; Amy E Ratliff; Donna M Crabb; Li Xiao; T Prescott Atkinson; Ken B Waites
Journal:  Emerg Infect Dis       Date:  2015-08       Impact factor: 6.883

9.  Molecular Detection and Evaluation of MLـ Resistance M. Pneumoniae Associated with Mutation in 23S RNA Gene among Iranian Patients with Respiratory Infections.

Authors:  Iman Pouladi; Reza Mirnejad; Susan Rostampur; Soghra Viesy; Mohammad Niakan
Journal:  Rep Biochem Mol Biol       Date:  2020-07

10.  The Prevalence of 23S rRNA Mutations in ML-Resistant M. pneumoniae Isolates to Clarithromycin in Patients with Respiratory Infections.

Authors:  Hanieh Big Mohammadi; Iman Pouladi; Mohammad Reza Zolfaghari; Mohammad Niakan
Journal:  Rep Biochem Mol Biol       Date:  2020-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.